Fe(II) coordination transition regulates reductive dechlorination: The overlooked abiotic role of lactate.

The coordination environment of Fe(II) significantly affect the reductive reactivity of Fe(II). Lactate is a common substrate for enhancing microbial dechlorination, but its effect on abiotic Fe(II)-driven reductive dechlorination is largely ignored. In this study, the structure-reactivity relationship of Fe(II) is investigated by regulating the ratio of lactate:Fe(II). This work shows that lactate-Fe(II) complexing enhances the abiotic Fe(II)-driven reductive dechlorination with the optimum lactate:Fe(II) ratio of 10:20. The formed hydrogen bond (Fe-OH∙∙∙∙∙∙O = C-) and Fe-O-C metal-ligand bond result in a reduced Fe(II) coordination number from six to four, which lead to the transition of Fe(II) coordination geometry from octahedron to tetrahedron/square planar. Coordinatively unsaturated Fe(II) results in the highest reductive dechlorination reactivity towards carbon tetrachloride (k1 = 0.26254 min-1). Excessive lactate concentration (> 10 mM) leads to an increased Fe(II) coordination number from four to six with a decreased reductive reactivity. Electrochemical characterization and XPS results show that lactate-Fe(II)-I (C3H5O3-:Fe(II) = 10:20) has the highest electron-donating capacity. This study reveals the abiotic effect of lactate on reductive dechlorination in a subsurface-reducing environment where Fe(II) is usually abundant.

Labile Fe(III) phase mediates the electron transfer from Fe(II,III) (oxyhydr)oxides to carbon tetrachloride.

Labile Fe(III) phase (includes Fe(III)aq, Fe(III)ads, or Fe(III)s species) is an important intermediate during the interaction between Fe(II) and Fe(III) (oxyhydr)oxides, but how does labile Fe(III) influence the electron transfer from Fe(II) to oxidant environmental pollutant during this Fe(II)-Fe(III) interaction is unclear. In this work, the dynamic change of Fe(II,III) (oxyhydr)oxides at the same time scale is simulated by synthesizing Fe(III)-Fe(II)-I (Fe(III)+NaOH+Fe(II)+NaOH) with different Fe(II)/Fe(III) ratios. CCl4 is used as a convenient probe to test the reduction kinetics of mixed valence Fe(II,III)(oxyhydr)oxides with different Fe(II):Fe(III) ratios. The Mössbauer spectra results reveal the Fe(III)labile in the solid phase is in octahedral coordination. The electron-donating capability of Fe(II) was improved with increasing Fe(III) content, but suppressed when [Fe(III)] ≥ 30 mM. The reductive dechlorination of CT by Fe(III)-Fe(II)-I decreased gradually with the increase of Fe(III) content, because more amount Fe(III)labile in solid phase is accumulated. This shows that the electron transfer from Fe(II) to Fe(III)labile rather than to CT is enhanced with increasing Fe(III) content. FTIR data shows that the hydroxylation of Fe(II) with Fe(OH)3 occurs preferentially in the non-hydrogen bonded hydroxyl group, causing the decrease of its reductive reactivity. The presence of [Fe(III)-O-Fe(II)]+ in Fe(III)-Fe(II)-I can stabilize the dichlorocarbene anion (:CCl2-), favouring the conversion of CT to CH4 (13.1%). The aging experiment shows that Fe(III)labile surface may maintain the reductive reactivity of Fe(II) during aging when [Fe(III)] = 5-20 mM. This study deepens our understanding of the mass transfer pathway of iron oxyhydroxides induced by Fe(II) and its impact on the reductive dechlorination of CT.

Reductive dehalogenation in groundwater by Si-Fe(II) co-precipitates enhanced by internal electric field and low vacancy concentrations.

Fe(II) and silicate can form Si-Fe(II) co-precipitates in anoxic groundwater and sediments, but their phase composition and reactivity towards subsurface pollutants are largely unknown. Three types of Si-Fe(II) co-precipitations with the same chemical composition, namely Si-Fe(II)-I, Si-Fe(II)-II, and Si-Fe(II)-III, have been synthesized by different hydroxylation sequences in this work. It was found that Si-Fe(II)-III reduce carbon tetrachloride (CT) much faster (k1=0.04419 min-1) than Si-Fe(II)-I (0 min-1) and Si-Fe(II)-II (7.860 × 10-4 min-1). XRD results show that the main component of Si-Fe(II)-III is ferrous silicate (FeSiO3), which is quite different from that of Si-Fe(II)-I and Si-Fe(II)-II. The unique arrangement of hydroxyl coordination, the less distorted octahedral structure, the polyhedral morphology and the absence of Si-A center vacancies in Si-Fe(II)-III are responsible for its high reductive dehalogenation reactivity. The highest redox activity of Si-Fe(II)-III was shown by electrochemical characterization. The [FeII-O-Si]+ in Si-Fe(II)-III may stabilize the dichlorocarbene anion (˸CCl2-), which favors the transformation of CT to methane (9.2%). The Si-Fe(II) co-precipitates consist of countless internal electric fields, and the transformation of hydroxyl and CT both consumed electrons. The coexistence of hydroxyl and CT increases the electron density in the electron-rich region due to their electronegativity, enhancing their electron-accepting capabilities. This study deepens our understanding of the phase composition and electronic structure of Si-Fe(II) co-precipitates, which fills the gap in the reductive dehalogenation of halides by Si-Fe(II) co-precipitates.

Hydroxyl groups bridge the electron transfer from Fe(II) to carbon tetrachloride.

Reductive dechlorination of chlorinated organic pollutants (COPs) by Fe(II) occurs in natural environments and engineered systems. Fe(II) ions undergo hydroxylation in aqueous solutions to form Ferrous Hydroxyl Complex (FHC), which plays an essential role in Fe(II)-mediated reductive dechlorination. However, how hydroxyl groups of FHC bridge the electron transfer from Fe(II) to COPs is still not fully understood. This work shows that the rate of reductive dechlorination of carbon tetrachloride (CT) by FHC increased with increasing OH- dosage. XRD data shows the increase of OH- dosage transform FHC from Fe2(OH)3Cl to Fe(OH)2, which leads to increased reductive strength of FHC. More non-hydrogen bonded hydroxyl groups coordinate with Fe(II) in FHC with increasing the OH- dosage, which stabilizes the octahedral structure of Fe(II) as shown by Mössbauer data. Electrochemical analysis reveals that the increase of OH- dosage enhances the reductive activity of FHC, which is also confirmed by the decreased HOMO-LUMO gap. It was found that FHC dechlorinated CT to methane, which was attributed to the stabilization of trichlorocarbene anion(˸CCl3-) by [surface-O-Fe(II)-OH]+. This work deepens our understanding on the bridge effect of hydroxyl groups on the electron transfer from Fe(II) to COPs, and provides a theoretical foundation for the reductive dechlorination of COPs in both natural environments and engineered systems.

The efficacy and adverse effects of the Uniblocker and left-side double-lumen tube for one-lung ventilation under the guidance of chest CT.

One-lung ventilation (OLV) is essential in numerous clinical procedures, in which the left-sided double-lumen tube (LDLT) is the most commonly used device. The application of bronchial blockers, including the Uniblocker or Arndt blocker, has increased in OLV. The present study aimed to compare the efficacy and adverse effects of the Uniblocker and LDLT for OLV under the guidance of chest CT. A total of 60 adult patients undergoing elective left-side thoracic surgery requiring OLV were included in the study. The patients were randomly assigned to the Uniblocker group (U group, n=30) or the LDLT group (D group, n=30). The time for initial tube placement, the number of optimal positions of the tube upon blind insertion, the number of attempts to adjust the tube to the optimal position, incidence of airway device displacement, injury to the bronchi and carina, the duration until lung collapse and the occurrence of sore throat and hoarseness over 24 h following surgery were recorded. The time for successful placement of the LDLT was 83.9±19.4 sec and that for the Uniblocker was 84.3±17.1 sec (P>0.05). The degree of lung collapse 1 min following opening of the pleura was greater in the D group than that in the U group (P<0.01) and the time required for the lung to completely collapse was shorter in the D group (3.3±0.5 min) than that in the U group (8.4±1.2 min; P<0.01). On the contrary, the incidence of injury to the bronchi and carina was lower in the U group (2/30 cases) than in the D group (10/30 cases; P=0.02); the incidence of sore throat was also lower in the U group (2/30 cases) compared with that in the D group (9/30 cases). The mean arterial pressure of patients immediately following intubation was lower in the U group (122.0±13.4 mmHg) than that in the D group (129.2±12.1 mmHg; P<0.05). The results of the present study indicated that the extraluminal use of the Uniblocker under guidance of chest CT is an efficient method with few adverse effects in left-side thoracic surgery. The study was registered at ClinicalTrials.gov on 16th December 2017 (no. NCT03392922).

[Migration and Transformation of Adsorbed Arsenic Mediated by Sulfate Reducing Bacteria].

In the natural environment, arsenic (As) is mainly adsorbed on iron oxide minerals. The release of adsorbed arsenic from iron oxide minerals to the water is the main source of arsenic pollution. Microbes play a crucial role for this process. The purpose of this study was to investigate the effect of the sulfate-reducing bacteria Desulfovibrio vulgaris DP4 on the transformation and mobilization of As. The experimental results show that the released As concentration of the two systems is 0 µmol·L-1 at 0 h. Compared with the control, DP4 promotes the desorption of As(Ⅴ) before the 84 h incubation process. The released As concentration reaches the maximum value of 12.6 µmol·L-1 at 13 h, accounting for~79% of the initial total adsorbed As (16 µmol·L-1). The maximum released As concentration is~8.4 times higher than that of the control (1.5 µmol·L-1). After 84 hours, the concentration of the released As in the DP4 system is lower than the abiotic control, which suggests that the released As is readsorbed on the solid surface. During the incubation process, the As mobility is significantly correlated with Eh. The XRD results show that the crystallinity of the solid samples in the DP4 system decreases by~50%. In general, a lower crystallinity of the adsorbent indicates a higher adsorption capacity. This may be one important reason for the As readsorption after 84 h. In addition, the SEM shows that goethite is agglomerated by DP4 and the EDS results indicate that goethite is partially transformed to an Fe-S mineral. Based on XANES, arsenic-sulfur minerals were not detected in the solid phase, which further confirms the SEM-EDS results, that is, that Fe-S minerals formed in the solid phase, rather than As2S3 (AsS). The released As was readsorbed on the secondary iron mineral, resulting in a lower dissolved As concentration in the DP4 system than in the abiotic control. Furthermore, 19% As(Ⅲ) was detected in the solid phase while dissolved As(Ⅲ) was not determined during the incubation process. The results suggest that sulfate-reducing bacteria may directly reduce adsorbed As(Ⅴ) to As(Ⅲ).

Rapamycin and CHIR99021 Coordinate Robust Cardiomyocyte Differentiation From Human Pluripotent Stem Cells Via Reducing p53-Dependent Apoptosis.

BACKGROUND: Cardiomyocytes differentiated from human pluripotent stem cells can serve as an unexhausted source for a cellular cardiac disease model. Although small molecule-mediated cardiomyocyte differentiation methods have been established, the differentiation efficiency is relatively unsatisfactory in multiple lines due to line-to-line variation. Additionally, hurdles including line-specific low expression of endogenous growth factors and the high apoptotic tendency of human pluripotent stem cells also need to be overcome to establish robust and efficient cardiomyocyte differentiation. METHODS AND RESULTS: We used the H9-human cardiac troponin T-eGFP reporter cell line to screen for small molecules that promote cardiac differentiation in a monolayer-based and growth factor-free differentiation model. We found that collaterally treating human pluripotent stem cells with rapamycin and CHIR99021 during the initial stage was essential for efficient and reliable cardiomyocyte differentiation. Moreover, this method maintained consistency in efficiency across different human embryonic stem cell and human induced pluripotent stem cell lines without specifically optimizing multiple parameters (the efficiency in H7, H9, and UQ1 human induced pluripotent stem cells is 98.3%, 93.3%, and 90.6%, respectively). This combination also increased the yield of cardiomyocytes (1:24) and at the same time reduced medium consumption by about 50% when compared with the previous protocols. Further analysis indicated that inhibition of the mammalian target of rapamycin allows efficient cardiomyocyte differentiation through overcoming p53-dependent apoptosis of human pluripotent stem cells during high-density monolayer culture via blunting p53 translation and mitochondrial reactive oxygen species production. CONCLUSIONS: We have demonstrated that mammalian target of rapamycin exerts a stage-specific and multifaceted regulation over cardiac differentiation and provides an optimized approach for generating large numbers of functional cardiomyocytes for disease modeling and in vitro drug screening.

Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism.

Inflammation is a relevant factor in the pathogenesis of diabetes nephropathy (DN). Sesquiterpene lactones (SLs), originally isolated from Tanacetum parthenium, have been reported to exhibit anti-inflammatory effects but few studies have examined their effects on DN. To determine whether advanced oxidation protein products (AOPPs) can induce the expression of chemokine monocyte chemoattractant protein- (MCP-) 1 in cultured mouse podocytes and to explore the mechanisms of the potential renoprotection of SLs, we treated podocytes with AOPPs and SLs (parthenolide and its derivatives micheliolide, compound 1, and compound 2). MCP-1 mRNA and protein expression were tested using quantitative real-time PCR and ELISA, respectively, and the protein levels of IKKß, phospho-IKKß, IκBα, NF-κB p65, phospho-NF-κB p65, and tubulin were analyzed by Western blotting. AOPPs activated the expression of MCP-1 mRNA and protein in a dose- and time-dependent manner, activated IKKß and NF-κB p65, and promoted IκBα degradation. The IKK/NF-κB inhibitor parthenolide decreased AOPP-induced MCP-1 expression. Pretreatment with SLs inhibited MCP-1 mRNA and protein expression and suppressed IKKß and NF-κB p65 phosphorylation and IκBα degradation. Taken together, these findings provide a novel explanation for the anti-inflammatory effects of SLs that will ultimately benefit DN and potentially other inflammatory and immune renal diseases.

AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-κB pathway in rat mesangial cells: inhibition by sesquiterpene lactones.

BACKGROUND: Monocyte chemoattractant protein-1 (MCP-1) plays an important role in extracellular matrix accumulation through macrophage recruitment and activation in the development and progression of diabetic nephropathy. Therefore, this study examined whether advanced oxidation protein products (AOPPs) are involved in nuclear factor-κB (NF-κB) activation and MCP-1 mRNA and protein expression in mesangial cells (MCs) and evaluated the effects of derivatives of sesquiterpene lactones (SLs) on AOPP-induced renal damage. METHODS: MCP-1 mRNA and protein expression in MCs were determined by quantitative real-time PCR and ELISA, respectively. The level of intracellular reactive oxygen species (ROS) was determined by flow cytometry. The protein expression of tubulin, P47, NF-κB p65, phospho-NF-κB p65, IκB, phospho-IκB, IKKß and phospho-IKKß was evaluated by Western blot. RESULTS: AOPPs caused oxidative stress in MCs and activated the NF-κB pathway by inducing IκBα phosphorylation and degradation. Inhibition of ROS by SOD (ROS inhibitor) blocked the AOPP-mediated NF-κB pathway. Moreover, the inhibition of AOPP-induced overproduction of MCP-1 mRNA and protein was associated with inhibition of IκBα degradation by SLs. CONCLUSION: AOPPs induce MCP-1 expression by activating the ROS/NF-κB pathway and can be inhibited by SLs. These findings may provide a novel approach to treat inflammatory and immune renal diseases, including diabetic nephropathy.

Sesquiterpene lactones and their derivatives inhibit high glucose-induced NF-κB activation and MCP-1 and TGF-ß1 expression in rat mesangial cells.

Diabetic nephropathy (DN) is one of the most common and serious chronic complications of diabetes mellitus, however, no efficient clinical drugs exist for the treatment of DN. We selected and synthesized several sesquiterpene lactones (SLs), and then used the MTT assay to detect rat mesangial cells (MCs) proliferation, ELISA to measure the expression level of monocyte chemoattractant protein-1 (MCP-1), transforming growth factor beta (TGF-ß1) and fibronectin(FN), real-time fluorescent quantitative PCR analysis to measure the MCP-1 and TGF-ß1 gene expression, western blot to detect the level of IκBα protein and EMSA to measure the activation of nuclear factor kappa B (NF-κB). We discovered that SLs, including parthenolide (PTL), micheliolide (MCL), arglabin, and isoalantolactone (IAL), as well as several synthetic analogs of these molecules, could effectively attenuate the high glucose-stimulated activation of NF-κB, the degradation of IκBα, and the expression of MCP-1, TGF-ß1 and FN in rat mesangial cells (MCs). These findings suggest that SLs and their derivatives have potential as candidate drugs for the treatment of DN.